Supporting Vitamin B17
"Few if any names in cancer research are as widely known as Kanematsu Sugiura’s... Possibly the highest regard in which his work is held is best characterized by a comment made by an investigator in cancer research from Russia. He said, "When Dr Sugiura publishes, we know we don’t have to repeat the study, for we would obtain the same results he has reported."" So wrote Dr C Chester Stock, Dr Kanematsu Sugiura, arguably America’s leading cancer biochemist of the ‘70s.
West Germany: Dr Hans Nieper: former Director of the Department of Medicine at Silbersee Hospital in Hanover in 1972, Dr Nieper told reporters: "After more than twenty years of such specialised work, I have found non-toxic nitrilosides that is, laetrile far superior to any other known cancer treatment or preventative. In my opinion, it is the only existing possibility for the ultimate control of cancer."
Canada: Dr N R Bouziane former Director of Research Laboratories at St Jeanne D’Arc Hospital in Montreal: his repeated successes in treating cancers with laetrile were written up in the Cancer News Journal, Jan/April 1971, p.20 under the article heading "The Laetrile Story".
Philippines: Dr Manuel Navarro, former Professor of Medicine and Surgery at the University of Santo Tomas, Manila. Associate Member of the National Research Council of the Philippines "It is my carefully considered clinical judgement, as a practising oncologist and researcher in this field, that I have obtained most significant and encouraging results with the use of laetrile-amygdalin in the treatment of terminal cancer patients... "
Mexico: Dr Ernesto Contreras, one of Mexico’s leading medical specialists has operated the Oasis Hospital in Tijuana Mexico for over 30 years, treating cancer patients with laetrile.
Italy: Professor Etore Guidetti of the University of Turin Medical School addressed the Conference of the International Union Against Cancer held in Brazil in 1954 and announced startling results with laetrile in successfully combating many types of cancer,including cervix, breast, uterus and rectum. After his speech, an American doctor rose in the audience, challenging the Italian professor that laetrile had been found to be worthless in the United States. Dr Guidetti was abrupt and dismissive: "I care not what was determined in the United States. I am merely reporting what I saw in my own clinic".
Belgium: Professor Joseph H Maisin.Sr from the University of Louvain, Director of the Institute of Cancer. Professor Maisin was also President Emeritus of the International League Against Cancer which holds the International Cancer Congress every four years.
United States:Among the many Dr Ernst T Krebs Jr. who developed laetrile. Dr Harold W Manner, professor of biology, Loyola University, Chicago. Dr H Ray Evers, Dr. Dan Dotson and Dr John A Richardson of Albany, New York. Dr John A Morrone of the Jersey City Medical Center. 60-year cancer researcher Dr Kanematsu Sugiura of Memorial Sloan-Kettering, and Dr Dean Burk a founding member of the American National Cancer Institute and head of its Cytochemistry Section.